Insider Buying Boosts Confidence in Company’s TCR‑T Cell Therapy Amid Market Downturn
Insider buying spurs confidence as the company’s TCR‑T cell therapy pushes toward IND approval, hinting at a future share price rebound.
4 minutes to read
Alaunos Therapeutics Inc